MOLINEAUX SUSANdirector, officer: PRESIDENT & CEOdirector, officer: PRESIDENT & ..
Common Stock
100,000
$0.85
$84,700
Purchase
DRACHMAN JONATHAN Gdirectordirector
Common Stock
200,000
$0.86
$172,000
Purchase
MOLINEAUX CHRISTOPHERofficer: SR. VP, DEVELOPMENTofficer: SR. VP, DEVELOPMENT
Common Stock
100,000
$0.85
$84,700
Sale
ORFORD KEITHdirectordirector
Common Stock
51,810
$0.84
$43,520
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
2,447
$6
$14,682
Sale
BVF PARTNERS L P/IL10 percent owner10 percent owner
Common Stock, $0.0001 par value
2,283,598
$6
$13,701,588
Sale
WONG STEPHANIEofficer: See Remarksofficer: See Remarks
Common Stock
5,000
$8
$40,000
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
3,021
$8
$24,168
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
3,021
$6
$18,126
Purchase
BVF PARTNERS L P/IL10 percent owner10 percent owner
Common Stock, $0.0001 par value
191,954
$3.91
$750,924
Purchase
BVF PARTNERS L P/IL10 percent owner10 percent owner
Common Stock, $0.0001 par value
128,488
$3.37
$433,005
Purchase
BVF PARTNERS L P/IL10 percent owner10 percent owner
Common Stock, $0.0001 par value
797,508
$2.7
$2,153,272
Purchase
BVF PARTNERS L P/IL10 percent owner10 percent owner
Common Stock, $0.0001 par value
1,598,977
$2.6
$4,157,340
Purchase
MOLINEAUX CHRISTOPHERofficer: SR. VP, DEVELOPMENTofficer: SR. VP, DEVELOPMENT
Common Stock
51,600
$3.88
$200,208
Purchase
MOLINEAUX SUSANdirector, officer: PRESIDENT & CEOdirector, officer: PRESIDENT & ..
Common Stock
51,600
$3.88
$200,208
Option
SJOGREN ERICofficer: SR. VP, DRUG DISCOVERYofficer: SR. VP, DRUG DISCOVERY
Employee Stock Option (Right to Buy)
21,739
$0.96
$20,869
Option
SJOGREN ERICofficer: SR. VP, DRUG DISCOVERYofficer: SR. VP, DRUG DISCOVERY
Common Stock
21,739
$0.96
$20,869
Option
WONG STEPHANIEofficer: See Remarksofficer: See Remarks
Employee Stock Option (Right to Buy)
10,000
$2.64
$26,400
Option
WONG STEPHANIEofficer: See Remarksofficer: See Remarks
Common Stock
10,000
$2.64
$26,400
Option
PARLATI FRANCESCOofficer: SR. VP, RESEARCHofficer: SR. VP, RESEARCH
Employee Stock Option (Right to Buy)
6,246
$2.64
$16,489
Option
PARLATI FRANCESCOofficer: SR. VP, RESEARCHofficer: SR. VP, RESEARCH
Common Stock
6,246
$2.64
$16,489
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
417
$6
$2,502
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
416
$6
$2,496
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
416
$6.33
$2,633
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
417
$6.43
$2,681
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
1,565
$6
$9,390
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
313
$6.05
$1,894
Sale
ORFORD KEITHofficer: CHIEF MEDICAL OFFICERofficer: CHIEF MEDICAL OFFICER
Common Stock
1,252
$6
$7,512
Option
SJOGREN ERICofficer: SR. VP, DRUG DISCOVERYofficer: SR. VP, DRUG DISCOVERY
Employee Stock Option (Right to Buy)
8,209
$0.48
$3,940
Option
SJOGREN ERICofficer: SR. VP, DRUG DISCOVERYofficer: SR. VP, DRUG DISCOVERY
Common Stock
16,810
$0.48
$8,069
Option
MOLINEAUX CHRISTOPHERofficer: SR. VP, DEVELOPMENTofficer: SR. VP, DEVELOPMENT
Employee Stock Option (Right to Buy)
33,790
$1.32
$44,603
Option
MOLINEAUX CHRISTOPHERofficer: SR. VP, DEVELOPMENTofficer: SR. VP, DEVELOPMENT
Common Stock
6,798
$2.64
$17,947
Option
MOLINEAUX SUSANdirector, officer: PRESIDENT & CEOdirector, officer: PRESIDENT & ..
Common Stock
26,992
$2.64
$71,259
Option
MOLINEAUX SUSANdirector, officer: PRESIDENT & CEOdirector, officer: PRESIDENT & ..
Employee Stock Option (Right to Buy)
33,790
$1.32
$44,603
Option
WONG STEPHANIEofficer: See Remarksofficer: See Remarks
Employee Stock Option (Right to Buy)
10,000
$2.64
$26,400
Option
WONG STEPHANIEofficer: See Remarksofficer: See Remarks
Common Stock
10,000
$2.64
$26,400
Option
PARLATI FRANCESCOofficer: SR. VP, RESEARCHofficer: SR. VP, RESEARCH
Common Stock
10,190
$0.96
$9,782
Option
PARLATI FRANCESCOofficer: SR. VP, RESEARCHofficer: SR. VP, RESEARCH
Employee Stock Option (Right to Buy)
1,979
$0.96
$1,900
Option
MOLINEAUX CHRISTOPHERofficer: SR. VP, DEVELOPMENTofficer: SR. VP, DEVELOPMENT
Common Stock
9,202
$1.8
$16,564
Option
MOLINEAUX SUSANdirector, officer: PRESIDENT & CEOdirector, officer: PRESIDENT & ..
Common Stock
12,868
$1.8
$23,162
Option
MOLINEAUX SUSANdirector, officer: PRESIDENT & CEOdirector, officer: PRESIDENT & ..
Common Stock
12,868
$1.8
$23,162
Option
MOLINEAUX SUSANdirector, officer: PRESIDENT & CEOdirector, officer: PRESIDENT & ..
Employee Stock Option (Right to Buy)
15,568
$1.2
$18,682
Option
MOLINEAUX CHRISTOPHERofficer: SR. VP, DEVELOPMENTofficer: SR. VP, DEVELOPMENT
Employee Stock Option (Right to Buy)
14,502
$1.2
$17,402
Option
MOLINEAUX CHRISTOPHERofficer: SR. VP, DEVELOPMENTofficer: SR. VP, DEVELOPMENT
Common Stock
9,202
$1.8
$16,564
Sale
ADAGE CAPITAL PARTNERS GP, L.L.C.10 percent owner10 percent owner
Common Stock
38,000
$15.5
$589,000
Sale
ADAGE CAPITAL PARTNERS GP, L.L.C.10 percent owner10 percent owner
Common Stock
186,000
$15.59
$2,899,740
Sale
ADAGE CAPITAL PARTNERS GP, L.L.C.10 percent owner10 percent owner
Common Stock, par value $0.0001 ("Common Stock")
352,000
$15.68
$5,519,360
Showing 1 to 50 of 108 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.